parallel review pilot
FDA, CMS Make Parallel Review Program Permanent; Will Device and Diagnostic Companies Engage?
Premium
After a five-year pilot, only one company has successfully taken a test through parallel review, but there is growing industry interest.
Foundation Medicine Pursuing Parallel Review by FDA, CMS for FoundationOne
The company hopes to simultaneously achieve premarket FDA approval and a national coverage determination from CMS for its NGS cancer panel.